DK1688149T3 - Pastaformulering omfattende silica - Google Patents

Pastaformulering omfattende silica

Info

Publication number
DK1688149T3
DK1688149T3 DK06005716T DK06005716T DK1688149T3 DK 1688149 T3 DK1688149 T3 DK 1688149T3 DK 06005716 T DK06005716 T DK 06005716T DK 06005716 T DK06005716 T DK 06005716T DK 1688149 T3 DK1688149 T3 DK 1688149T3
Authority
DK
Denmark
Prior art keywords
silica
pasta formulation
pasta
formulation
Prior art date
Application number
DK06005716T
Other languages
Danish (da)
English (en)
Inventor
Jun Chen
Original Assignee
Merial Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Ltd filed Critical Merial Ltd
Application granted granted Critical
Publication of DK1688149T3 publication Critical patent/DK1688149T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Physiology (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK06005716T 2000-02-16 2001-02-05 Pastaformulering omfattende silica DK1688149T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/504,741 US6787342B2 (en) 2000-02-16 2000-02-16 Paste formulations
PCT/EP2001/001155 WO2001060409A1 (en) 2000-02-16 2001-02-05 Improved paste formulations

Publications (1)

Publication Number Publication Date
DK1688149T3 true DK1688149T3 (da) 2009-06-29

Family

ID=24007536

Family Applications (2)

Application Number Title Priority Date Filing Date
DK06005716T DK1688149T3 (da) 2000-02-16 2001-02-05 Pastaformulering omfattende silica
DK01905731T DK1263467T3 (da) 2000-02-16 2001-02-05 Silicaholdige pastaformuleringer

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK01905731T DK1263467T3 (da) 2000-02-16 2001-02-05 Silicaholdige pastaformuleringer

Country Status (20)

Country Link
US (1) US6787342B2 (ja)
EP (2) EP1688149B9 (ja)
JP (1) JP2003522805A (ja)
AR (1) AR029655A1 (ja)
AT (2) ATE327769T1 (ja)
AU (2) AU3373801A (ja)
BR (1) BRPI0108449B8 (ja)
CA (1) CA2400317C (ja)
CY (2) CY1105626T1 (ja)
CZ (1) CZ304469B6 (ja)
DE (2) DE60120122T2 (ja)
DK (2) DK1688149T3 (ja)
ES (2) ES2326426T3 (ja)
HK (1) HK1094321A1 (ja)
NZ (2) NZ520707A (ja)
PL (1) PL203304B1 (ja)
PT (2) PT1688149E (ja)
RU (2) RU2304962C2 (ja)
WO (1) WO2001060409A1 (ja)
ZA (1) ZA200206484B (ja)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6429320B1 (en) * 2000-08-04 2002-08-06 Cognis Corporation Processes for the purification of tocopherol and/or sterol compounds and compositions containing orthoborate ester mixtures
US7988999B2 (en) * 2000-12-07 2011-08-02 Nycomed Gmbh Pharmaceutical preparation in the form of a paste comprising an acid-labile active ingredient
US6893652B2 (en) 2001-08-27 2005-05-17 Wyeth Endoparasiticidal gel composition
US7943160B2 (en) 2002-05-09 2011-05-17 Scimetrics Limited Corp. Pest control methods
US20060205681A1 (en) * 2002-06-21 2006-09-14 Maryam Moaddeb Homogenous paste formulations
US7001889B2 (en) 2002-06-21 2006-02-21 Merial Limited Anthelmintic oral homogeneous veterinary pastes
US20040151759A1 (en) * 2002-08-16 2004-08-05 Douglas Cleverly Non-animal product containing veterinary formulations
US20040037869A1 (en) * 2002-08-16 2004-02-26 Douglas Cleverly Non-animal product containing veterinary formulations
AU2002952597A0 (en) * 2002-11-11 2002-11-28 Schering-Plough Pty. Limited Topical parasiticide formulations and methods of treatment
NZ523128A (en) * 2002-12-12 2006-01-27 Ashmont Holdings Ltd Anthelmintic formulations containing avermectins and or milbemycins
PL1610613T3 (pl) 2003-04-04 2017-06-30 Merial, Inc. Miejscowe preparaty weterynaryjne przeciw robakom
AU2003100262B4 (en) * 2003-04-07 2003-09-18 Jurox Pty Ltd Stable carprofen composition
US7671034B2 (en) * 2003-12-19 2010-03-02 Merial Limited Stabilized formulation of ivermectin feed premix with an extended shelf life
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
WO2006042381A1 (en) * 2004-10-21 2006-04-27 Parnell Laboratories (Aust) Pty Limited Anti-inflammatory preparation
KR20070121746A (ko) * 2005-03-14 2007-12-27 매크로켐 코포레이션 사람 피부를 통한 마크롤라이드 침투의 개선
US7955632B2 (en) * 2005-12-07 2011-06-07 Bayer B.V. Process for manufacturing chewable dosage forms for drug delivery and products thereof
US20080027011A1 (en) * 2005-12-20 2008-01-31 Hassan Nached Homogeneous paste and gel formulations
CN103483260B (zh) 2006-07-05 2016-08-03 梅瑞尔公司 1-芳基-5-烷基吡唑衍生化合物、其制备方法和使用方法
NZ552040A (en) * 2006-12-13 2009-04-30 Bomac Research Ltd Veterinary formulation comprising an anthelmintic compound and glyceryl acetate
MX2009006656A (es) * 2007-03-05 2009-08-07 Merial Ltd Formulaciones homogeneas en pasta y gel.
SI3428148T1 (sl) 2007-05-15 2021-04-30 Boehringer Ingelheim Animal Health USA Inc. Ariloazol-2-il cianoetilamino spojine, postopek njihove izdelave in postopek njihove uporabe
US20110118243A1 (en) * 2008-03-20 2011-05-19 Lynn Chambers Anti-inflammatory drug delivery system
US9820977B2 (en) * 2008-10-03 2017-11-21 Bayer Healthcare Llc Systemic treatment of blood-sucking and blood-consuming parasites by oral administration of a parasiticidal agent
CA2945453C (en) 2008-11-14 2021-03-02 Merial, Inc. Enantiomerically enriched aryloazol-2-yl cyanoethylamino paraciticidal compounds
AP3359A (en) 2008-11-19 2015-07-31 Merial Ltd Compositions comprising 1-arylpyrazole alone or incombination with formamidine for the treatment of parasitic infection
AU2009322206B2 (en) 2008-12-04 2015-03-05 Boehringer Ingelheim Animal Health USA Inc. Dimeric avermectin and milbemycin derivatives
GB0905365D0 (en) 2009-03-27 2009-05-13 Norbrook Lab Ltd A topical parasiticide composition
CA2769385C (en) 2009-07-30 2017-10-17 Merial Limited Insecticidal 4-amino-thieno[2,3-d]-pyrimidine compounds and methods of their use
AU2010325827B2 (en) 2009-12-04 2015-11-05 Basf Se Pesticidal bis-organosulfur compounds
PL3078664T3 (pl) 2009-12-17 2019-08-30 Merial Inc. Dihydroazolowe kompozycje przeciwpasożytnicze
US8980896B2 (en) 2009-12-17 2015-03-17 Merial, Inc. Compositions comprising macrocyclic lactone compounds and spirodioxepinoindoles
UA108641C2 (uk) 2010-04-02 2015-05-25 Паразитицидна композиція, яка містить чотири активних агенти, та спосіб її застосування
LT2640728T (lt) 2010-11-16 2017-03-27 Merial, Inc. Nauji monenzino dariniai, skirti pirmuonių sukeltų infekcijų gydymui
CA2840396C (en) 2011-06-27 2020-07-14 Merial Limited Amido-pyridyl ether compounds and compositions and their use against parasites
US20120329832A1 (en) 2011-06-27 2012-12-27 Jean Delaveau Novel Insect-Repellent Coumarin Derivatives, Syntheses, and Methods of Use
ES2938566T3 (es) * 2011-10-11 2023-04-12 Baxter Int Composiciones hemostaticas
JP6249568B2 (ja) 2011-11-17 2017-12-20 メリアル インコーポレイテッド アリールピラゾールと置換イミダゾールを含む組成物、その使用方法
WO2013082373A1 (en) 2011-12-02 2013-06-06 Merial Limited Long-acting injectable moxidectin formulations and novel moxidectin crystal forms
PL230178B1 (pl) 2012-02-06 2018-09-28 Merial Ltd Weterynaryjne miękkie, nadające się do żucia kompozycje przeciwpasożytnicze obejmujące działające systemowo substancje czynne oraz zastosowania je obejmujące
AU2015261543C1 (en) * 2012-02-27 2022-10-13 Elanco New Zealand Controlled release compositions and their methods of use
CN104244983A (zh) * 2012-02-27 2014-12-24 拜耳新西兰有限公司 控制释放组合物及其使用方法
BR112014024833B1 (pt) 2012-04-04 2022-10-04 Intervet International B.V. Produto farmacêutico veterinário mastigável macio, processo para sua fabricação e seu uso, bem como uso de pamoato de sódio
RU2486905C1 (ru) * 2012-05-28 2013-07-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Кубанский государственный технологический университет" (ФГБОУ ВПО "КубГТУ") Средство для лечения мастита у животных
US20180042953A1 (en) * 2012-06-08 2018-02-15 Obshchestvo S Ogranichennoy Otvetstvennostyu "Vik - Zdorovye Zhivotnykh" Antibacterial injectable pharmaceutical composition
RU2512683C2 (ru) * 2012-06-08 2014-04-10 Общество с ограниченной ответственностью "ВИК-здоровье животных" Антибактериальная инъекционная фармацевтическая композиция
EP3428162B1 (en) 2012-11-20 2021-05-05 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic compounds and compositions and method of using thereof
US20150238654A1 (en) * 2012-12-18 2015-08-27 Gregory J. Pomrink Irrigation resistant compositions for regeneration of hard tissues and methods and kits of using the same
KR102341193B1 (ko) 2013-11-01 2021-12-17 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 구충 및 살충성의 이속사졸린 화합물
US10045979B2 (en) 2014-05-19 2018-08-14 Merial Inc. Anthelmintic compounds
RU2707298C2 (ru) 2015-05-20 2019-11-26 Мериал, Инк. Противогельминтные депсипептидные соединения
KR101614814B1 (ko) 2015-11-13 2016-04-22 바이엘코리아주식회사 집먼지진드기 구제 조성물
WO2017121740A1 (en) 2016-01-15 2017-07-20 Basf Se Conductive paste
UY37137A (es) 2016-02-24 2017-09-29 Merial Inc Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de acción prolongada que los comprenden, métodos y usos de los mismos
WO2018039508A1 (en) 2016-08-25 2018-03-01 Merial, Inc. Method for reducing unwanted effects in parasiticidal treatments
BR112019007605A2 (pt) 2016-10-14 2019-09-17 Boehringer Ingelheim Animal Health Usa Inc compostos pesticidas e parasiticidas de vinil isoxazolina
CA3044038A1 (en) 2016-11-16 2018-05-24 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic depsipeptide compounds
KR102679493B1 (ko) 2017-01-31 2024-07-01 킴벌리-클라크 월드와이드, 인크. 벤조산 에스테르를 포함하는 항균 조성물 및 이를 이용한 세균 생장 억제 방법
EP3381479A1 (de) * 2017-03-29 2018-10-03 ARTOSS GmbH Trägerzusammensetzung für knochenersatzmaterialien
BR112020003217A2 (pt) 2017-08-14 2020-10-06 Boehringer Ingelheim Animal Health USA Inc. compostos pesticidas e parasiticidas de pirazolisoxazolina
WO2019157241A1 (en) 2018-02-08 2019-08-15 Boehringer Ingelheim Animal Health USA Inc. Parasiticidal compositions comprising eprinomectin and praziquantel, methods and uses thereof
IL279977B2 (en) 2018-07-09 2024-06-01 Boehringer Ingelheim Animal Health Usa Inc Heterocyclic anthelmintic compounds
WO2020112374A1 (en) 2018-11-20 2020-06-04 Boehringer Ingelheim Animal Health USA Inc. Indazolylcyanoethylamino compound, compositions of same, method of making, and methods of using thereof
JP2022526901A (ja) 2019-03-19 2022-05-27 ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド 駆虫性アザベンゾチオフェンおよびアザベンゾフラン化合物
CN111387179B (zh) * 2020-04-29 2021-11-12 河北威远生物化工有限公司 一种阿维菌素B2a溶剂化固体及其制备方法
EP4185589A1 (en) 2020-05-29 2023-05-31 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic heterocyclic compounds

Family Cites Families (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US537195A (en) 1895-04-09 Conduit electric railway
US2562830A (en) 1951-07-31 Derivatives
US11637A (en) 1854-09-05 Flour-bolt
US3337570A (en) 1965-10-23 1967-08-22 Schering Corp Substituted nicotinic acids and method for the manufacture thereof
US3904682A (en) 1967-01-13 1975-09-09 Syntex Corp 2-(6{40 -Methoxy-2{40 -naphthyl)acetic acid
US4009197A (en) 1967-01-13 1977-02-22 Syntex Corporation 2-(6-Substituted-2'-naphthyl) acetic acid derivatives and the salts and esters thereof
NL160809C (nl) 1970-05-15 1979-12-17 Duphar Int Res Werkwijze ter bereiding van benzoylureumverbindingen, alsmede werkwijze ter bereiding van insekticide prepara- ten op basis van benzoylureumverbindingen.
BE792990A (fr) 1971-12-23 1973-06-19 Shell Int Research Procede de lutte contre les endoparasites chez les chevaux
US3950360A (en) 1972-06-08 1976-04-13 Sankyo Company Limited Antibiotic substances
US3896145A (en) 1972-07-24 1975-07-22 Hoffmann La Roche Carbazoles
US3818047A (en) 1972-08-07 1974-06-18 C Henrick Substituted pyrones
SE434277B (sv) 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
CH604517A5 (ja) 1976-08-19 1978-09-15 Ciba Geigy Ag
US5089490A (en) 1977-04-02 1992-02-18 Hoechst Aktiengesellschaft Cephem derivatives
GB2006492B (en) 1977-08-12 1982-01-20 English Electric Co Ltd Input circuits
US4199569A (en) 1977-10-03 1980-04-22 Merck & Co., Inc. Selective hydrogenation products of C-076 compounds and derivatives thereof
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US4465663A (en) 1981-07-27 1984-08-14 Basf Wyandotte Corporation Polyoxybutylene-polyoxyethylene aqueous gels
US4343785A (en) 1981-08-10 1982-08-10 Basf Wyandotte Corporation Gel dentifrice compositions
US4427663A (en) 1982-03-16 1984-01-24 Merck & Co., Inc. 4"-Keto-and 4"-amino-4"-deoxy avermectin compounds and substituted amino derivatives thereof
JPS59199673A (ja) 1983-04-25 1984-11-12 Sumitomo Chem Co Ltd 含窒素複素環化合物、その製造法およびそれを有効成分とする有害生物防除剤
US4476107A (en) 1983-06-13 1984-10-09 Basf Wyandotte Corporation Mouthwash composition
US4511563A (en) 1983-07-15 1985-04-16 Basf Wyandotte Corporation Clear analgesic gels with reduced tackiness
DE3333639A1 (de) * 1983-09-17 1985-03-28 Dynamit Nobel Ag Zubereitung von nitroestern fuer die koronartherapie
DE3340680A1 (de) 1983-11-10 1985-05-23 Henkel Kgaa Verfahren zur erhoehung der viskositaet von oelen
US4686092A (en) 1984-04-13 1987-08-11 Union Carbide Corporation Manganese-aluminum-phosphorus-silicon-oxide molecular sieves
DE3580444D1 (en) 1984-10-18 1990-12-13 Ciba Geigy Ag Benzoylphenylharnstoffe.
US4781920A (en) * 1984-11-13 1988-11-01 American Cyanamid Company Anthelmintic paste compositions containing resinates of d1-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole
DE3681465D1 (ja) 1985-02-04 1991-10-24 Nihon Bayer Agrochem K.K., Tokio/Tokyo, Jp
US4562936A (en) * 1985-02-12 1986-01-07 The Procter & Gamble Company Easy-open laminated container with optional reclosing means and method of making
ES8800986A1 (es) 1985-07-27 1987-12-01 Pfizer Un procedimiento para la produccion de un nuevo derivado de avermectina
GB8713768D0 (en) 1987-06-12 1987-07-15 May & Baker Ltd Compositions of matter
EP0237482A1 (de) 1986-03-06 1987-09-16 Ciba-Geigy Ag C(29)-Carbonyloxi-milbemycin-Derivate zur Bekämpfung von tier- und pflanzenparasitären Schädlingen
BR8701302A (pt) 1986-03-25 1987-12-22 Sankyo Co Compostos macrolideos,sua preparacao e seu uso
ES2039258T3 (es) 1986-07-02 1993-09-16 Ciba-Geigy Ag Pesticidas.
US4758435A (en) 1986-08-11 1988-07-19 American Cyanamid Company Estradiol implant composition and method for preparation
US4855317A (en) 1987-03-06 1989-08-08 Ciba-Geigy Corporation Insecticides and parasiticides
US4871719A (en) 1987-03-24 1989-10-03 Ciba-Geigy Corporation Composition for controlling parasites in productive livestock
US4874749A (en) 1987-07-31 1989-10-17 Merck & Co., Inc. 4"-Deoxy-4-N-methylamino avermectin Bla/Blb
EP0319142B1 (en) 1987-11-03 1994-04-06 Beecham Group Plc Intermediates for the preparation of anthelmintic macrolide antibiotics
US4891211A (en) 1988-06-29 1990-01-02 Church & Dwight Co., Inc. Stable hydrogen peroxide-releasing dentifice
US5215890A (en) 1988-11-03 1993-06-01 Spyros Theodoropulos Chromogenic substrate to peroxidase enzymes
JP2694361B2 (ja) 1989-02-09 1997-12-24 アストラ アクチエボラグ 抗菌剤
NZ232422A (en) 1989-02-16 1992-11-25 Merck & Co Inc 13-ketal milbemycin derivatives and parasiticides
US5288496A (en) 1990-05-15 1994-02-22 Stolle Research & Development Corporation Growth promoters for animals
CA2036147A1 (en) 1990-06-29 1991-12-30 Hiroki Tomioka A 1-pyridylimidazole derivative and its production and use
SI9011409A (en) 1990-07-18 1995-10-31 Pliva Pharm & Chem Works O-methyl azitromycin derivates, methods and intermediates for their preparation and methods for preparation of pharmaceuticals products which comprise them
US5072716A (en) 1990-07-30 1991-12-17 Toxoric, Inc. Archery bow sighting device
US5122377A (en) 1990-11-19 1992-06-16 A.H. Robins, Company, Incorporated Oral delivery system for veterinary drugs
CA2064634C (en) 1991-04-04 1998-08-04 James V. Heck 9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions
DE69204942T2 (de) * 1991-08-19 1996-02-08 Weissenfluh Hawe Neos Zahnputzmittel.
AU658681B2 (en) * 1991-10-23 1995-04-27 Block Drug Company Inc., The Penetration enhancement of topically applied formulations
US5288469A (en) 1992-03-16 1994-02-22 Envirosurgical, Inc. Surgery plume filter device
IL105155A (en) 1992-04-24 1999-05-09 Astra Ab Synergistic combination of an inhibitor of gastric acid secretion with an acid-breaking antibiotic
US5210235A (en) 1992-08-26 1993-05-11 Merck & Co., Inc. Methods of elaborating erythromycin fragments into amine-containing fragments of azalide antibiotics
HRP930014A2 (en) 1993-01-08 1994-08-31 Pliva Pharm & Chem Works 9-deoxo-9a-aza-11-deoxy-9a-homoeritromycin a 9a, 11-cyclic carbamates
US5332807A (en) 1993-04-14 1994-07-26 Merck & Co., Inc. Process of producing 8A- and 9A-azalide antibiotics
GB9300883D0 (en) 1993-01-18 1993-03-10 Pfizer Ltd Antiparasitic agents
GB9602877D0 (en) * 1996-02-13 1996-04-10 Merck Frosst Canada Inc 3,4-Diaryl-2-hydroxy-2,5- dihydrofurans as prodrugs to cox-2 inhibitors
US5399582A (en) 1993-11-01 1995-03-21 Merck & Co., Inc. Antiparasitic agents
HRP931480B1 (en) 1993-12-08 1997-08-31 Sour Pliva 9a-N-(N'-CARBAMONYL) and 9a-N-(N'-THIOCARBAMONYL) DERIVATES OF 9-DEOXO-9a-HOMOERYTHROMYCIN A
JP3715994B2 (ja) 1993-12-21 2005-11-16 住友化学株式会社 害虫防除剤
US5958458A (en) * 1994-06-15 1999-09-28 Dumex-Alpharma A/S Pharmaceutical multiple unit particulate formulation in the form of coated cores
EP0819000B1 (en) 1995-03-20 2009-07-08 Merck & Co., Inc. Nodulisporic acid derivatives
IT1275955B1 (it) * 1995-03-22 1997-10-24 Dompe Spa Formulazioni farmaceutiche in forma di gel tissotropico
US5708017A (en) * 1995-04-04 1998-01-13 Merck & Co., Inc. Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors
US6020343A (en) * 1995-10-13 2000-02-01 Merck Frosst Canada, Inc. (Methylsulfonyl)phenyl-2-(5H)-furanones as COX-2 inhibitors
US5981576A (en) * 1995-10-13 1999-11-09 Merck Frosst Canada, Inc. (Methylsulfonyl)phenyl-2-(5H)-furanones as COX-2 inhibitors
ES2122905B1 (es) 1996-07-11 1999-11-16 Astur Pharma Sa Sintesis de 11,12-hidrogenoortoborato de 9-desoxo-9a-aza-11,12-desoxi-9a-metil-9a-homoeritromicina a. un procedimiento para la preparacion de 9-desoxo-9a-aza-9a-metil-9a-homoeritromicina a dihidrato (azitromicina dihidrato).
US5939090A (en) * 1996-12-03 1999-08-17 3M Innovative Properties Company Gel formulations for topical drug delivery
US5880076A (en) * 1997-08-04 1999-03-09 Lever Brothers Company, Division Of Conopco, Inc. Compositions comprising glycacarbamate and glycaurea compounds
US5888523A (en) * 1997-09-22 1999-03-30 Biocontrol, Inc. Topical non-steroidal anti-inflammatory drug composition
IL129102A0 (en) 1999-03-22 2000-02-17 J P M E D Ltd An emulsion

Also Published As

Publication number Publication date
PT1263467E (pt) 2006-08-31
DE60120122D1 (de) 2006-07-06
EP1263467B1 (en) 2006-05-31
ZA200206484B (en) 2003-10-16
CA2400317A1 (en) 2001-08-23
US6787342B2 (en) 2004-09-07
NZ532434A (en) 2005-09-30
RU2007120070A (ru) 2008-12-10
RU2304962C2 (ru) 2007-08-27
RU2452468C2 (ru) 2012-06-10
EP1688149A1 (en) 2006-08-09
PL356429A1 (en) 2004-06-28
RU2002124584A (ru) 2004-03-10
BRPI0108449B1 (pt) 2018-02-27
BR0108449A (pt) 2003-04-01
JP2003522805A (ja) 2003-07-29
AR029655A1 (es) 2003-07-10
AU2001233738B2 (en) 2005-11-03
PT1688149E (pt) 2009-07-31
DE60120122T2 (de) 2006-09-21
ES2326426T3 (es) 2009-10-09
CZ20022772A3 (cs) 2003-01-15
CY1105626T1 (el) 2010-12-22
CY1109286T1 (el) 2014-07-02
CZ304469B6 (cs) 2014-05-21
CA2400317C (en) 2009-04-21
ES2266157T3 (es) 2007-03-01
EP1688149B9 (en) 2009-09-09
AU3373801A (en) 2001-08-27
ATE327769T1 (de) 2006-06-15
HK1094321A1 (en) 2007-03-30
WO2001060409A1 (en) 2001-08-23
NZ520707A (en) 2004-07-30
DE60138660D1 (de) 2009-06-18
EP1263467A1 (en) 2002-12-11
EP1688149B1 (en) 2009-05-06
ATE430583T1 (de) 2009-05-15
DK1263467T3 (da) 2006-10-02
US20030007958A1 (en) 2003-01-09
PL203304B1 (pl) 2009-09-30
BRPI0108449B8 (pt) 2021-05-25

Similar Documents

Publication Publication Date Title
DK1688149T3 (da) Pastaformulering omfattende silica
ATE306928T1 (de) Fulvestrant formulierung
NO20025176D0 (no) Multippelstigerörreaktor
ID30590A (id) Celana sekali pakai jenis-celana pendek
DE60044147D1 (de) Knetvorrichtung
ID30187A (id) Dongkrak jenis pantagraf
DE50101916D1 (de) Flüssige formulierungen
DE60117753D1 (de) Raupenband kaoutchouk
DE60137169D1 (de) Entwicklungsgerät
AR028336A1 (es) 4-hidroxi-tetrahidropiridonas fenilsubstituidas
DE50109748D1 (de) Hydrolager
DK1307733T3 (da) Creatininsensor-kalibrering
ATE268116T1 (de) Mesotrion-formulierungen
ATE270044T1 (de) Fungizide formulierung
AR027982A1 (es) Aril- y heteroarilsulfonatos
DE60217710D1 (de) Neue formulierung
FI20000573A0 (fi) Rengaskuristin
AT500246B8 (de) Chokerring
FI20001002A0 (fi) Pastatuotteet
ATA12252000A (de) Regensinkkasten
ATA11602000A (de) Sonnenstandsnachführungssystem
ATA21172000A (de) Hackbrett
SE0100199D0 (sv) New formulation
SE0100477D0 (sv) Novel formulation
SE0100478D0 (sv) Novel formulation